| Literature DB >> 11562780 |
T Okamoto1, S Y Jeong, Y Takahashi, K W Baughman, K Ogata, J Goto, I Kanazawa.
Abstract
Calcium channel blocker is useful for a variety of purposes and is effective for preventing hepatitis elicited by different inducers, suggesting its possible clinical application for treating hepatitis. The alpha1-subunit of the dihydropyridine-sensitive L-type calcium channel is a target of calcium channel blocker. For clinical application of calcium channel blocker, it is important to analyze the expression of the L-type calcium channel in the liver. However, the subtype of the L-type calcium channel alpha1-subunit expressed in the liver was not known. In the present study, the alpha1-subunit of the calcium channel expressed in human liver was systematically analyzed. The alpha1D subunit of the dihydropyridine-sensitive L-type voltage gated calcium channel is expressed relatively strongly in the liver and may play an important role in the liver.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11562780 DOI: 10.3892/ijmm.8.4.413
Source DB: PubMed Journal: Int J Mol Med ISSN: 1107-3756 Impact factor: 4.101